The histone deacetylase inhibitor Suberoylanilide Hydroxamic Acid (SAHA) as a therapeutic agent in rhabdomyosarcoma

Rhabdomyosarcoma (RMS) is an aggressive childhood sarcoma with two distinct subtypes, embryonal (ERMS) and alveolar (ARMS) histologies. More effective treatment is needed to improve outcomes, beyond conventional cytotoxic chemotherapy. The pan-histone deacetylase inhibitor, Suberoylanilide Hydroxami...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Biol Ther
Autors principals: Ghayad, Sandra E., Rammal, Ghina, Sarkis, Omar, Basma, Hussein, Ghamloush, Farah, Fahs, Assil, Karam, Mia, Harajli, Mohamad, Rabeh, Wissam, Mouawad, Joe E., Zalzali, Hassan, Saab, Raya
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2018
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6370390/
https://ncbi.nlm.nih.gov/pubmed/30307360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2018.1529093
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars